Answers are grounded in this paper and cite their sources.
To report a case of FIGO 2018 stage IVB PD-L1-positive cervical squamous cell carcinoma successfully managed with neoadjuvant immunochemotherapy followed by conversion surgery and maintenance systemic therapy, highlighting the feasibility and potential benefit of a multimodal approach in selected patients. A 61-year-old postmenopausal woman with cervical cancer and distant lymph node metastases (pelvic, para-aortic, and left supraclavicular) was treated with six cycles of neoadjuvant therapy comprising a PD-1 inhibitor, paclitaxel, cisplatin, and bevacizumab. This was followed by two additional cycles of PD-1 inhibitor and bevacizumab alone. Radiologic evaluation identified significant regression of metastatic lesions and shrinkage of the primary cervical tumor. However, mild re-enlargement of the cervical lesion was noted on follow-up imaging. Robotic-assisted radical hysterectomy, pelvic and para-aortic lymphadenectomy, and partial vaginectomy were performed based on multidisciplinary consensus and patient preference. Postoperative adjuvant therapy and maintenance treatment ensued. Neoadjuvant treatment resulted in partial response with significant reduction in both target and non-target lesions. Despite mild re-enlargement of the primary cervical lesion after chemotherapy de-escalation, surgery was pursued. Pathology revealed minimal residual disease confined to the cervical stroma without nodal metastasis. The patient completed four cycles of adjuvant therapy and achieved complete response. She has since remained disease-free on maintenance therapy with bevacizumab and a PD-1 inhibitor, with a follow-up duration of 16 months from the initial diagnosis. This case illustrates that, in selected PD-L1-positive FIGO stage IVB cervical cancer patients with resectable distant metastases and no parametrial invasion, a multimodal approach combining systemic immunochemotherapy with anti-angiogenic agents, followed by robotic-assisted conversion surgery and personalized postoperative management, can achieve complete response and potentially curative outcomes. Robotic surgery also facilitates complex procedures in anatomically constrained spaces, supporting its role in advanced-stage cervical cancer management. This treatment model may offer a viable strategy to prolong progression-free and overall survival in carefully selected patients.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: